• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与体外膜肺氧合。

Obesity and Extracorporeal Membrane Oxygenation.

机构信息

Dr Coccola is affiliated with Division of Critical Care, Department of Pediatrics, UH Rainbow Babies and Children's Hospital and Case Western Reserve University School of Medicine, Cleveland, Ohio. Dr Remy is affiliated with Division of Critical Care, Department of Pediatrics, UH Rainbow Babies and Children's Hospital and Case Western Reserve University School of Medicine, Cleveland, Ohio; and Division of Pulmonary Critical Care, Department of Medicine, University Hospitals of Cleveland and Case Western Reserve University School of Medicine, Cleveland, Ohio. Dr Cheifetz is affiliated with Division of Cardiac Critical Care, Department of Pediatrics, UH Rainbow Babies and Children's Hospital and Case Western Reserve University School of Medicine, Cleveland, Ohio.

出版信息

Respir Care. 2024 Mar 27;69(4):474-481. doi: 10.4187/respcare.11565.

DOI:10.4187/respcare.11565
PMID:38538017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11108105/
Abstract

Obesity is increasing in prevalence worldwide and carries a theoretical increased risk of morbidity and mortality in critical illness, including hypercoagulability, thrombosis, and renal dysfunction. Obesity has historically been considered a relative contraindication to candidacy for extracorporeal membrane oxygenation (ECMO); however, recent research has suggested that obesity may be associated with improved outcomes in ECMO. This review was conducted to assess and synthesize the existing literature on ECMO outcomes in the obese population. We searched PubMed, Scopus, and CENTRAL databases for obesity and ECMO outcomes, and articles were screened independently by 2 authors. The selection process yielded 29 articles, with one ambispective and 28 retrospective cohort studies. Analyses of these studies show no evidence of globally increased mortality or complications in obesity. Prospective evaluation is needed to further investigate this relationship, but there is currently no evidence to support using body mass index as exclusionary criteria for ECMO.

摘要

肥胖症在全球范围内的患病率不断增加,在危重病中存在理论上增加发病率和死亡率的风险,包括高凝状态、血栓形成和肾功能障碍。肥胖症在历史上被认为是体外膜氧合(ECMO)候选资格的相对禁忌症;然而,最近的研究表明,肥胖症可能与 ECMO 中的改善结局相关。进行这项综述是为了评估和综合肥胖人群中 ECMO 结局的现有文献。我们在 PubMed、Scopus 和 CENTRAL 数据库中搜索了肥胖症和 ECMO 结局的相关文章,并由 2 名作者独立筛选文章。选择过程产生了 29 篇文章,其中 1 篇为前瞻性和 28 篇回顾性队列研究。这些研究的分析表明肥胖症并没有增加死亡率或并发症的全球证据。需要进行前瞻性评估来进一步研究这种关系,但目前没有证据支持使用体重指数作为 ECMO 的排除标准。

相似文献

1
Obesity and Extracorporeal Membrane Oxygenation.肥胖与体外膜肺氧合。
Respir Care. 2024 Mar 27;69(4):474-481. doi: 10.4187/respcare.11565.
2
Should Obesity Be an Exclusion Criterion for Extracorporeal Membrane Oxygenation Support? A Scoping Review.肥胖应作为体外膜肺氧合支持的排除标准吗?一项范围综述。
Anesth Analg. 2024 Aug 1;139(2):300-312. doi: 10.1213/ANE.0000000000006745. Epub 2023 Nov 27.
3
Obesity associated with improved mortality of extracorporeal membrane oxygenation for severe COVID-19 pneumonia.肥胖与 COVID-19 重症肺炎体外膜肺氧合治疗死亡率改善相关。
Perfusion. 2024 Sep;39(6):1161-1166. doi: 10.1177/02676591231178896. Epub 2023 May 25.
4
Extracorporeal membrane oxygenation for critically ill adults.危重症成人的体外膜肺氧合
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010381. doi: 10.1002/14651858.CD010381.pub2.
5
Nutrition and outcomes in venovenous extracorporeal membrane oxygenation: An observational cohort study.静脉-静脉体外膜肺氧合中的营养与预后:一项观察性队列研究。
Nutr Clin Pract. 2025 Feb;40(1):117-124. doi: 10.1002/ncp.11132. Epub 2024 Feb 20.
6
Obesity and Extracorporeal Membrane Oxygenation (ECMO): Analysis of Outcomes.肥胖与体外膜肺氧合(ECMO):结局分析。
J Cardiothorac Vasc Anesth. 2024 Jan;38(1):285-298. doi: 10.1053/j.jvca.2023.10.025. Epub 2023 Oct 21.
7
Body mass index does not impact survival in COVID-19 patients requiring veno-venous extracorporeal membrane oxygenation.体重指数对需要静脉-静脉体外膜肺氧合的 COVID-19 患者的生存没有影响。
Perfusion. 2023 Sep;38(6):1174-1181. doi: 10.1177/02676591221097642. Epub 2022 Apr 25.
8
Mortality in Patients with Obesity and Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation: The Multicenter ECMObesity Study.肥胖合并急性呼吸窘迫综合征患者接受体外膜肺氧合治疗的死亡率:多中心 ECMObesity 研究。
Am J Respir Crit Care Med. 2023 Sep 15;208(6):685-694. doi: 10.1164/rccm.202212-2293OC.
9
Impact of obesity on outcomes of extracorporeal membrane oxygenation support: a systematic review and meta-analysis.肥胖对体外膜肺氧合支持结局的影响:系统评价和荟萃分析。
BMC Pulm Med. 2024 Mar 28;24(1):157. doi: 10.1186/s12890-024-02971-5.
10
Association Between Body Mass Index and Outcomes in Venoarterial Extracorporeal Membrane Oxygenation.体重指数与静脉-动脉体外膜肺氧合治疗结局之间的关联
Anesth Analg. 2022 Feb 1;134(2):341-347. doi: 10.1213/ANE.0000000000005689.

本文引用的文献

1
Obesity associated with improved mortality of extracorporeal membrane oxygenation for severe COVID-19 pneumonia.肥胖与 COVID-19 重症肺炎体外膜肺氧合治疗死亡率改善相关。
Perfusion. 2024 Sep;39(6):1161-1166. doi: 10.1177/02676591231178896. Epub 2023 May 25.
2
Outcomes Following Extracorporeal Membrane Oxygenation for Severe COVID-19 in Pregnancy or Post Partum.体外膜肺氧合治疗妊娠或产后严重 COVID-19 的结局。
JAMA Netw Open. 2023 May 1;6(5):e2314678. doi: 10.1001/jamanetworkopen.2023.14678.
3
The impact of BMI on arrest characteristics and survival of patients with out-of-hospital cardiac arrest treated with extracorporeal cardiopulmonary resuscitation.BMI 对接受体外心肺复苏治疗的院外心脏骤停患者的复苏特征和存活率的影响。
Resuscitation. 2023 Jul;188:109842. doi: 10.1016/j.resuscitation.2023.109842. Epub 2023 May 15.
4
The Relation Between Obesity and Mortality in Postcardiotomy Venoarterial Membrane Oxygenation.体外循环术后应用膜肺氧合患者的肥胖与死亡率的关系。
Ann Thorac Surg. 2023 Jul;116(1):147-154. doi: 10.1016/j.athoracsur.2023.03.025. Epub 2023 Apr 2.
5
Impact of BMI on outcomes in respiratory ECMO: an ELSO registry study.BMI 对呼吸体外膜肺氧合结局的影响:ELSO 注册研究。
Intensive Care Med. 2023 Jan;49(1):37-49. doi: 10.1007/s00134-022-06926-4. Epub 2022 Nov 22.
6
The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox.肥胖对大容量 ECMO 中心严重 SARS-CoV-2 ARDS 结局的影响:ECMO 和皮质类固醇支持肥胖悖论。
J Crit Care. 2022 Dec;72:154162. doi: 10.1016/j.jcrc.2022.154162. Epub 2022 Oct 8.
7
Impact of Obesity on In-Hospital Outcomes in Veno-Arterial ECMO Patients.肥胖对静脉-动脉体外膜肺氧合患者住院结局的影响。
Heart Lung Circ. 2022 Oct;31(10):1393-1398. doi: 10.1016/j.hlc.2022.03.014. Epub 2022 Aug 1.
8
Body mass index does not impact survival in COVID-19 patients requiring veno-venous extracorporeal membrane oxygenation.体重指数对需要静脉-静脉体外膜肺氧合的 COVID-19 患者的生存没有影响。
Perfusion. 2023 Sep;38(6):1174-1181. doi: 10.1177/02676591221097642. Epub 2022 Apr 25.
9
The Use of Extracorporeal Membrane Oxygenation in COVID-19 Patients with Severe Cardiorespiratory Failure: The Influence of Obesity on Outcomes.体外膜肺氧合在 COVID-19 合并严重心肺衰竭患者中的应用:肥胖对结局的影响。
J Extra Corpor Technol. 2021 Dec;53(4):293-298. doi: 10.1182/ject-2100034.
10
Effect of Body Mass Index on the Clinical Outcomes of Adult Patients Treated With Venoarterial ECMO for Cardiogenic Shock.体重指数对因心原性休克接受脉动脉体外膜肺氧合治疗的成年患者临床结局的影响。
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2376-2384. doi: 10.1053/j.jvca.2021.11.012. Epub 2021 Nov 12.